Abstract
Studies have suggested a possible association between inflammatory bowel disease (IBD) and the Philadelphia-negative chronic myeloproliferative neoplasms (MPNs). The mechanisms behind this association have not been investigated yet, but in this review, we find it most likely to involve complex interactions between genetic, treatment-related and inflammation- and immune-mediated factors. When patients with IBD present with persistent leukocytosis and/or thrombocytosis, it may reflect concomitant MPN, and early detection and treatment of MPNs may prevent some of the complications related to these diseases.
| Translated title of the contribution | Myeloproliferative neoplasms and chronic inflammatory bowel disease |
|---|---|
| Original language | Danish |
| Journal | Ugeskrift for Laeger |
| Volume | 182 |
| Issue number | 22 |
| ISSN | 0041-5782 |
| Publication status | Published - 5 May 2020 |
Fingerprint
Dive into the research topics of 'Myeloproliferative neoplasms and chronic inflammatory bowel disease'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS